| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 40.77B | 37.92B | 26.68B | 27.46B | 27.57B | 30.12B |
| Gross Profit | 6.00B | 5.47B | 3.78B | 3.19B | 4.36B | 3.05B |
| EBITDA | -580.11M | 6.10B | 2.57B | 369.13M | 2.61B | 1.34B |
| Net Income | -1.17B | 5.03B | 740.70M | -519.89M | 885.50M | -116.83M |
Balance Sheet | ||||||
| Total Assets | 43.83B | 44.41B | 29.63B | 29.08B | 32.77B | 32.34B |
| Cash, Cash Equivalents and Short-Term Investments | 4.10B | 4.26B | 3.64B | 2.80B | 5.14B | 5.91B |
| Total Debt | 6.40B | 6.64B | 4.82B | 5.43B | 8.35B | 9.94B |
| Total Liabilities | 22.87B | 22.63B | 13.93B | 13.89B | 17.79B | 18.55B |
| Stockholders Equity | 19.28B | 19.97B | 14.50B | 14.15B | 13.98B | 12.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.32B | 889.58M | -20.02M | 824.08M | 871.87M |
| Operating Cash Flow | 0.00 | -34.08M | 1.52B | 993.15M | 1.29B | 1.76B |
| Investing Cash Flow | 0.00 | 78.62M | 191.69M | -698.65M | -366.67M | -721.52M |
| Financing Cash Flow | 0.00 | 743.16M | -896.77M | -3.17B | -1.77B | 2.34B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥134.02B | 11.39 | ― | 3.72% | 5.40% | 14.80% | |
76 Outperform | ¥90.80B | 12.64 | ― | 3.04% | 1.57% | -33.97% | |
73 Outperform | ¥69.47B | 20.79 | ― | 1.92% | -0.86% | 17.65% | |
71 Outperform | ¥24.68B | 10.51 | ― | 3.61% | 8.85% | 110.05% | |
68 Neutral | ¥81.88B | 18.48 | ― | 2.22% | 5.17% | 79.36% | |
66 Neutral | ¥7.58B | -8.15 | ― | 2.84% | 37.67% | -117.29% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |